PROTAC/分子胶药物研发服务
PROTAC分子结构研究合作案例：
时间：2022-08-22
来源：澳门永利welcome
分享：
【摘要】：
Source：Dragovich PS, et, al. Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy. J Med Chem. 2021 Mar 11;64(5):2576-2607.
Source： Chung CW, et, al. Structural Insights into PROTAC-Mediated Degradation of Bcl-xL. ACS Chem Biol. 2020 Sep 18;15(9):2316-2323.
媒体联络方式vivapr@vivabiotech.com
联系我们
Copyright © 澳门永利welcome All Rights Reserved. 沪ICP备19036061号